Cencora expands Sure Supply Program, adds 200 critical medications amid shortages

Cencora, a global healthcare company, has expanded its Sure Supply Program to include 200 critical medications, including several oncology treatments, in response to ongoing drug shortages. This marks a 350% increase since the initiative first launched in 2021. 

Advertisement

The Sure Supply Program is designed to provide health systems with reliable access to medications at risk of shortage, offering a six-month safety stock reserve based on each health system’s purchasing commitments, according to a Feb. 6 news release from the company. 

In 2023, over 99% of hospital and health system pharmacists reported drug shortages, driving an increase in demand for mitigation solutions. By negotiating long-term agreements with manufacturers to produce additional inventory, Cencora aims to stabilize the supply chain and reduce the strain on hospitals. 

The expanded program covers a range of therapeutic areas, including oncology, critical care, cardiovascular and infectious diseases.

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Pharmacy

Advertisement

Comments are closed.